News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Loophole Offers Pfizer Inc. (PFE) A Risky Way Back Into A Deal With AstraZeneca PLC (AZN)


5/21/2014 7:04:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pfizer has a risky way back into a deal with AstraZeneca. An apparent loophole in Britain’s takeover code means that the American pharmaceutical giant could offer the 58.85 pounds-a-share demanded by Astra for a recommendation, even after declaring that the earlier £55-a-share pitch was “final.”

Help employers find you! Check out all the jobs and post your resume.

Read at New York Times
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES